Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
about
mTOR signaling in growth control and diseaseTreatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patientsA novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretionDEP domain-containing mTOR-interacting protein in the rat brain: distribution of expression and potential implication.Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation.Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism.The effects of TORC signal interference on lipogenesis in the oleaginous yeast Trichosporon oleaginosus.Rapamycin up-regulates triglycerides in hepatocytes by down-regulating Prox1The multifaceted role of mTORC1 in the control of lipid metabolismRapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue.Microbial drug discovery: 80 years of progress.mTORC1 signaling in energy balance and metabolic disease.Animal models for the atherosclerosis research: a review.The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses.mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretionLongitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats.
P2860
Q24634174-A47AB7C0-D8EC-4FEE-898C-9BCAAD6236E5Q26996051-C1FED579-B03C-480E-B155-1DA8377FC784Q33741229-1BD67E7F-F127-4293-89EC-00B88FCB6D2AQ34435266-1D85633E-24CB-4C70-B89C-BE216888E45BQ34538168-D906E816-F70F-44E8-8ABD-109B8FD7B108Q35024616-6CD86FEA-98F6-4F32-8537-698EF30133CBQ36300157-35B74D75-5ABA-4E56-918F-C62828A85A17Q36626489-4D8590D3-65E9-442A-9582-E6D255443B46Q36659049-8411D7E7-FF95-480B-8F68-C1AD5300DBBDQ36725815-7C23648B-7E08-4CAF-9AA4-074C211B48B1Q37365189-B1D79B4B-BB5B-4047-B8AD-3986087F41CCQ37793822-1D2BA489-8C66-43CB-A675-4FFA916E4AE5Q37862141-0FEBFED0-943D-4AD4-98FB-C1AE9A9949D0Q38115702-3BDFC37E-AFA1-436A-B0BD-28B750C2243CQ41441726-9ACC298E-4AC0-4876-BF0A-CB7C1359608EQ42154664-BCDE6ECF-7815-48AE-98C9-32AEEC00E4D0Q47119839-B2D09D4D-E514-4881-ABAE-7C1264FF3633Q51325820-50AF2C0B-49D0-4204-AED9-C19472042D92
P2860
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
@en
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
@nl
type
label
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
@en
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
@nl
prefLabel
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
@en
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs.
@nl
P1433
P1476
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs
@en
P2093
Dimple Aggarwal
Maria Luz Fernandez
P304
P356
10.1016/J.METABOL.2006.01.017
P577
2006-06-01T00:00:00Z